Richard Hobbs

96.9k total citations · 13 hit papers
557 papers, 24.0k citations indexed

About

Richard Hobbs is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Richard Hobbs has authored 557 papers receiving a total of 24.0k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Cardiology and Cardiovascular Medicine, 84 papers in Surgery and 78 papers in Epidemiology. Recurrent topics in Richard Hobbs's work include Blood Pressure and Hypertension Studies (93 papers), Heart Failure Treatment and Management (82 papers) and Atrial Fibrillation Management and Outcomes (67 papers). Richard Hobbs is often cited by papers focused on Blood Pressure and Hypertension Studies (93 papers), Heart Failure Treatment and Management (82 papers) and Atrial Fibrillation Management and Outcomes (67 papers). Richard Hobbs collaborates with scholars based in United Kingdom, United States and Qatar. Richard Hobbs's co-authors include Jonathan Mant, Andrea Roalfe, Jason Oke, Daniel Lasserson, Jennifer Hirst, Christopher A. O’Callaghan, Nathan R. Hill, Samuel Fatoba, David Fitzmaurice and Richard J. McManus and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Richard Hobbs

524 papers receiving 23.0k citations

Hit Papers

Global Prevalence of Chronic Kidney... 2002 2026 2010 2018 2016 2007 2018 2002 2011 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
    2016 2.6k citations Jason Oke, Richard Hobbs et al. profile →
  2. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    2007 1.1k citations Jonathan Mant, Richard Hobbs et al. profile →
  3. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
    2018 855 citations Annie Young, Andrea Marshall et al. Journal of Clinical Oncology profile →
  4. International Clinical Recommendations on Scar Management
    2002 746 citations Richard Hobbs et al. profile →
  5. ESC/EAS Guidelines for the management of dyslipidaemias
    2011 576 citations Richard Hobbs et al. profile →
  6. Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007–14
    2016 446 citations Richard Hobbs, Clare Bankhead et al. profile →
  7. Survival of Patients with Chronic Heart Failure in the Community: A Systematic Review and Meta-Analysis
    2019 348 citations Andrea Roalfe, Richard Hobbs et al. European Journal of Heart Failure profile →
  8. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study
    2019 320 citations Clare Taylor, Andrea Roalfe et al. profile →
  9. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
    2021 180 citations Ly‐Mee Yu, Simon de Lusignan et al. profile →
  10. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
    2021 140 citations Richard Stevens, Richard J. McManus et al. profile →
  11. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
    2022 127 citations Richard Hobbs et al. profile →
  12. Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)
    2023 124 citations Richard Hobbs et al. profile →
  13. Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe
    2024 34 citations Richard Hobbs et al. profile →

Peers

Richard Hobbs
Finlay A. McAlister Canada
John S. Rumsfeld United States
Robert J. Goldberg United States
Muhammad Mamdani Canada
Frederick A. Masoudi United States
Vic Hasselblad United States
Yuchiao Chang United States
Paul A. Heidenreich United States
John J. McNeil Australia
Théodore G. Ganiats United States
Finlay A. McAlister Canada
Richard Hobbs
Citations per year, relative to Richard Hobbs Richard Hobbs (= 1×) peers Finlay A. McAlister

Countries citing papers authored by Richard Hobbs

Since Specialization
Citations

This map shows the geographic impact of Richard Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hobbs more than expected).

Fields of papers citing papers by Richard Hobbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hobbs. The network helps show where Richard Hobbs may publish in the future.

Co-authorship network of co-authors of Richard Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hobbs. A scholar is included among the top collaborators of Richard Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hobbs. Richard Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheppard, James P, Eleanor Temple, Ariel Wang, et al.. (2024). Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial. The Lancet Healthy Longevity. 5(8). e563–e573. 6 indexed citations
2.
Virdee, Pradeep S., Claire Friedemann Smith, Xin Yang, et al.. (2024). The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal. Cancers. 16(9). 1692–1692. 3 indexed citations
3.
4.
Lusignan, Simon de, et al.. (2023). A targeted approach to vaccine hesitancy. PubMed. 4(1). iqad007–iqad007.
5.
Bedston, Stuart, Emily Lowthian, Christopher I Jarvis, et al.. (2023). COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study. Vaccine. 41(7). 1378–1389. 4 indexed citations
6.
Jowett, Sue, Gary A. Ford, Richard Hobbs, et al.. (2022). Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial. Hypertension. 79(5). 1122–1131. 7 indexed citations
7.
8.
Young, Annie, Andrea Marshall, Oliver Chapman, et al.. (2018). Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). Journal of Clinical Oncology. 36(20). 2017–2023. 855 indexed citations breakdown →
9.
10.
Ashdown, Helen, et al.. (2017). What are General Practitioner perceptions of workload in England? A qualitative study. British Journal of General Practice. 3 indexed citations
11.
Lowres, Nicole, David Fitzmaurice, Richard Hobbs, et al.. (2017). Abstract 20082: Guideline-based Screening for Atrial Fibrillation: Analysis of Yield and Stroke Risk. Circulation. 2 indexed citations
12.
13.
Taylor, Clare, et al.. (2012). Ten-Year Prognosis of Heart Failure in the Community: Follow-Up Data from the Echocardiographic Heart of England Screening (ECHOES) Study. European Journal of Heart Failure. 14(2). 176–184. 51 indexed citations
14.
Walraven, Carl van, Robert G. Hart, Stuart J. Connolly, et al.. (2009). Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation. Stroke. 40(4). 1410–1416. 234 indexed citations
15.
Ryan, Ronan, Richard J. McManus, Jonathan Mant, John Macleod, & Richard Hobbs. (2009). Statins in heart failure: Retrospective cohort study using routine primary care data. Annals of Medicine. 41(7). 490–496. 5 indexed citations
16.
Erhardt, Leif, Michel Komajda, Richard Hobbs, & Jordi Soler‐Soler. (2008). Cardiologists' Awareness and Perceptions of Guidelines for Chronic Heart Failure. The ADDress Your Heart Survey. European Journal of Heart Failure. 10(10). 1020–1025. 33 indexed citations
17.
Freemantle, Nick, et al.. (2006). The availability of inhaled human insulin may lead to a greater acceptance of insulin therapy in European type 2 diabetes patients failing on diet and/or oral agent therapy. UCL Discovery (University College London). 1 indexed citations
18.
Hobbs, Richard, J Korewicki, John G.F. Cleland, Joanne Eastaugh, & Nick Freemantle. (2005). The Diagnosis of Heart Failure in European Primary Care: The IMPROVEMENT Programme Survey of Perception and Practice. European Journal of Heart Failure. 7(5). 768–779. 26 indexed citations
19.
Hobbs, Richard. (2004). Guidelines and management of global risk: the European perspective. European Heart Journal Supplements. 1 indexed citations
20.
Hobbs, Richard. (2004). Guidelines and management of global risk: the European perspective. European Heart Journal Supplements. 6. C5–C14. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Finlay A. McAlister Breakdown of academic impact, for papers by John S. Rumsfeld Breakdown of academic impact, for papers by Robert J. Goldberg Breakdown of academic impact, for papers by Muhammad Mamdani Breakdown of academic impact, for papers by Frederick A. Masoudi Breakdown of academic impact, for papers by Vic Hasselblad Breakdown of academic impact, for papers by Yuchiao Chang Breakdown of academic impact, for papers by Paul A. Heidenreich Breakdown of academic impact, for papers by John J. McNeil Breakdown of academic impact, for papers by Théodore G. Ganiats
Rankless by CCL
2026